Track the 바이오니아 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오니아 has published 61 public disclosures. The latest transaction was filed on 4 February 2026 (Other). Among the most active insiders: 이중열. The full history is free.
61
Insider Decl.
n/a
Thresholds
n/a
20 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioNia is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.
